A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Clinical trial NCT02791191 · TERMINATED
Trial details
- NCT number
- NCT02791191
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-16
- Primary completion
- 2018-07-02
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.